Systemic therapies for the management of non–clear cell renal cell carcinoma: what works, what doesn't, and what the future holds

P Zoumpourlis, G Genovese, NM Tannir… - Clinical genitourinary …, 2021 - Elsevier
Non–clear cell renal cell carcinoma (nccRCC) is a broad term that refers to a diverse group
of tumors, each with its own distinct biologic and therapeutic profile. The management of …

Start of a new era: Management of non-clear cell renal cell carcinoma in 2022

BL Maughan - Current Oncology Reports, 2022 - Springer
Abstract Purpose of Review Historically, kidney cancer was diagnosed as either clear cell
renal carcinoma (ccRCC) or non-clear cell renal carcinoma (nccRCC). With further research …

Survival after cytoreductive nephrectomy in metastatic non-clear cell renal cell carcinoma patients: a population-based study

M Marchioni, M Bandini, F Preisser, Z Tian… - European urology …, 2019 - Elsevier
Background The benefit of cytoreductive nephrectomy (CNT) for cancer-specific mortality
(CSM)-free survival is unclear in contemporary metastatic non-clear cell renal cell carcinoma …

Update in collecting duct carcinoma: Current aspects of the clinical and molecular characterization of an orphan disease

C Suarez, D Marmolejo, A Valdivia… - Frontiers in …, 2022 - frontiersin.org
Collecting duct renal cell carcinoma (cdRCC), which until recently was thought to arise from
the collecting ducts of Bellini in the renal medulla, is a rare and aggressive type of non-clear …

Navigating the current landscape of non-clear cell renal cell carcinoma: a review of the literature

A John, L Spain, AA Hamid - Current Oncology, 2023 - mdpi.com
Non-clear cell renal cell carcinoma (nccRCC) is an entity comprised of a heterogeneous
constellation of RCC subtypes. Genomic profiling has broadened our understanding of …

Clinical features and prognostic outcome of renal collecting duct carcinoma: 12 cases from a single institution

X Qian, Z Wang, J Zhang, Q Wang, P Zhou… - Cancer management …, 2020 - Taylor & Francis
Purpose Collecting duct carcinoma (CDC) is extremely rare and has high malignancy and
poor prognosis. The purpose of this research is to explore the clinical characteristic …

Comprehensive molecular characterization of collecting duct carcinoma for therapeutic vulnerability

P Guan, J Chen, C Mo, T Fukawa, C Zhang… - EMBO Molecular …, 2024 - embopress.org
Collecting duct carcinoma (CDC) is an aggressive rare subtype of kidney cancer with unmet
clinical needs. Little is known about its underlying molecular alterations and etiology …

Complete response to combination therapy with nivolumab and ipilimumab for metastatic collecting duct carcinoma of the kidney

K Watanabe, T Sugiyama, A Otsuka… - … cancer conference journal, 2020 - Springer
Collecting duct carcinoma (CDC) of the kidney is a rare subtype of renal cell carcinoma
(RCC) arising from the distal collecting tubules, characterized by an aggressive phenotype …

Marital status and survival in patients with renal cell carcinoma

Y Li, M Zhu, S Qi - Medicine, 2018 - journals.lww.com
Marital status and survival in patients with renal cell carc... : Medicine Marital status and survival
in patients with renal cell carcinoma : Medicine Log in or Register Get new issue alertsGet …

Immune checkpoint inhibitors in non-conventional histologies of renal-cell carcinoma

M Bersanelli, SE Rebuzzi, G Roviello… - Human Vaccines & …, 2023 - Taylor & Francis
For years, prospective randomized clinical trials excluded patients with non-conventional
histologies of renal cell carcinoma (RCC). The paucity of data has led to adopting the same …